Summary
The Pfizer COVID 19 inoculations have come under scrutiny for potential harm and failure to adhere to established safety protocols. Concerns have been raised regarding biased reporting by pharmaceutical companies, including Pfizer. The trials conducted by Pfizer have been criticised for their design, with flaws in the comparison groups and endpoints. The immunobridging trials conducted for children were not designed to prove safety and efficacy relative to a placebo. Additionally, post marketing pharmacovigilance reports have raised alarm about data falsification and unblinding of participants. Conflicts of interest among authors of Pfizer reports have also been highlighted, raising questions about the integrity of the research. The negative effectiveness of the Pfizer vaccine against the Omicron variant and the increased risk of illness in vaccinated individuals have further fuelled concerns. Given these findings, calls have been made for the immediate withdrawal of the Pfizer inoculations to protect the public from potential harm.